Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 308

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 308
---
 the Deloitte Global Network, an independent registered public accounting firm |
| 23.2*  |     | Consent of Doron Tikotzky                                                                                                         
 Kantor Gutman & Amit Gross (included in Exhibit 5.1)                                                                              |
| 23.3*  |     | Consent of Greenberg Traurig,                                                                                                     
 LLP (included in Exhibit 5.2)                                                                                                     |
| 24.1** |     | Power of Attorney (included in signature pages of Registration Statement)                                                         |
| 99.1*  |     | Consent of Dr. Susan Alpert                                                                                                       
 as Director Nominee                                                                                                               |
| 99.2*  |     | Consent of Pini Ben-Elazar                                                                                                        
 as Director Nominee                                                                                                               |
| 99.3*  |     | Consent of Efraim Cohen-Arazi                                                                                                     
 as Director Nominee                                                                                                               |
| 107**  |     | Filing Fee Table                                                                                                                  |

| *  | To be filed by amendment.                                   |
| ** | Filed herewith.                                             |
| +  | Indicates a management                                      
 contract or any compensatory plan, contract or arrangement. |

<div align='center'>II-8

SIGNATURES</div>

Pursuant to the requirements of the Securities Act of 1933, as amended,
the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and
has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Herzliya, Israel
on this day of 10, 2025.

| REGENTIS BIOMATERIALS LTD. |                         |
| By:                        | /s/ Dr. Eli Hazum       |
|                            | Dr. Eli Hazum,          |
|                            | Chief Executive Officer |

<div align='center'>POWER OF ATTORNEY</div>

The undersigned officers and directors of Regentis
Biomaterials Ltd. hereby constitute and appoint Dr. Eli Hazum and Arie Gordashnikov with full power of substitution, our true and
lawful attorney-in-fact and agent to take any actions to enable the Company to comply with the Securities Act, and any rules, regulations
and requirements of the SEC, in connection with this Registration Statement on Form F-1, including the power and authority to sign
for us in our